Log In

 

Company Name : Takeda Pharmaceutical Company Limited

Wednesday, January 24, 2018 12:20PM IST (6:50AM GMT)

(BW)(TAKEDA-PHARMACEUTICAL)

Takeda Recognized as a Global 100 Most Sustainable Corporation for Third Consecutive Year


Osaka, Japan

Takeda Pharmaceutical Company Limited [TOKYO:4502], (“Takeda”) is proud to be named by Corporate Knights as one of the 2018 Global 100 Most Sustainable Corporations in the World (Global 100) for the third consecutive year. This distinction is based on 17 key performance indicators including financial management, clean revenue, and supplier performance. Takeda performed in the top 25% on innovation capacity, receiving notable recognition for its leadership diversity. Global 100 companies in 2018 represent the top 1.3% in the world on sustainability performance. The Index launched in 2005; results are disclosed annually at the World Economic Forum in Davos.

 

As a LEAD company within the United Nations Global Compact, Takeda’s established track record in sustainability is guided by long-term international targets such as the Sustainable Development Goals (SDGs). Takeda is the only Japanese pharmaceutical company and among the four companies from Japan to make the final 100 in 2018, and one of just ten pharmaceutical companies in the world to be listed.

 

“Takeda is honored to be recognized once again for our commitment to sustainability, particularly alongside such distinguished global corporations,” said Haruhiko Hirate, Corporate Communications & Public Affairs Officer. “We strive to create and maximize long-term economic, social, and environmental value worldwide, led by our unique and diverse corporate governance, through our corporate social responsibility (CSR), which contributes to the lasting health of patients worldwide through long-term investments in disease prevention, capacity building, and access to healthcare. As a company, Takeda strives for Better Health and a Brighter Future for people worldwide through leading innovation in medicine, together with the global community.”

 

In addition to the Global 100 Index, Takeda is recognized by multiple Socially Responsible Investment (SRI) valuations.
 

Name of Index/Investment
Universe/Ratings

 

Company/
Organization Conducting
Assessment

  Country   Honors Awarded
Dow Jones Sustainability Asia Pacific Index   S&P Dow Jones Indices   US   8th consecutive year
FTSE4Good Global Index   FTSE Russel   UK   13th consecutive year
Ethibel EXCELLENCE Investment Register   Forum Ethibel   BEL   three times
Prime Status   Oekom   GER   first time
 

About Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited (TOKYO:4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. Innovative products, especially in oncology and gastroenterology, as well as Takeda’s presence in emerging markets, are currently fueling the growth of Takeda. Approximately 30,000 Takeda employees are committed to improving quality of life for patients, working with Takeda’s partners in health care in more than 70 countries.
For more information, visit https://www.takeda.com/newsroom/.

 

Additional information about Takeda is available through its Sustainable Value Report, https://www.takeda.com/corporate-responsibility/Sustainable-Value-Report/.

 

 

 

 


Click here for Media Contact Details
CONTACTS :

Media Contacts:
Japanese Media
Takeda Pharmaceutical Company Limited
Satoko Imai, +81-3-3278-2037
satoko.imai@takeda.com


More News from Takeda Pharmaceutical Company Limited

18/02/2018 1:30PM

Takeda Announces Its Certification in Select Group of Global Top Employers® 2018

Takeda Pharmaceutical Company Limited (TOKYO: 4502), (“Takeda”) announced it has become part of a select group of only thirteen (13) companies and one of two pharmaceuticals to receive global Top ...

03/02/2018 7:43PM

Takeda Reports 3rd Quarter FY2017 Results

Takeda Pharmaceutical Company Limited (TOKYO:4502):   Underlying Revenue growth +6.7% led by Takeda's Growth Drivers   Underlying Revenue grew +6.7% year-to-date, with Takeda's Growth ...

30/01/2018 4:55PM

Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation

Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, ...

Similar News

24/02/2018 10:40PM

Mother Who Lost Infant Son to Medical Error to Join Panel at World Patient Safety, Science & Technology Summit

New mother Deahna Visscher was feeling hopeful. Although her son Grant had been born with a heart defect, he was doing very well after surgery. Just 11-days old, doctors felt he could soon leave the hospital. But that ...

No Image

23/02/2018 7:40PM

Wipro and Amrita Vishwa Vidyapeetham Jointly Win the Aegis Graham Bell Award 2017 for Innovation in 'mHealth'

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company and Amrita Vishwa Vidyapeetham have jointly won the Aegis Graham Bell Award ...